Use of Bivalirudin for Anticoagulation in Interventional Cardiovascular Procedures
Anticoagulation is imperative to reduce the incidence of thrombotic complications in patients undergoing percutaneous interventional cardiovascular procedures; however, this is at the expense of increased risk of bleeding. The optimal anticoagulation strategy for these procedures remains unclear. Un...
| Published in: | Cardiovascular Innovations and Applications |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
Compuscript Ltd
2018-06-01
|
| Online Access: | https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2017.0045 |